@prefix this: . @prefix sub: . @prefix xsd: . @prefix dct: . @prefix prov: . @prefix np: . @prefix orcid: . @prefix nt: . @prefix schema: . @prefix nkg: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { schema:possibleTreatment sub:medtherapy . sub:medtherapy prov:wasDerivedFrom sub:quote; schema:drug ; schema:targetPopulation sub:targetpop; nkg:indicationType nkg:SymptomaticReliefIndication . sub:quote prov:value "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis"; prov:wasQuotedFrom . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0003-4665-7473 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB"; npx:hasSignature "RSo+0Z1NrVv9aS1gn0lWhVGhnCza0qEjRmg5X8ZpIjQ/UQTGjZE0IfHpqlzcm1vFKdHlFWPs+Od96qgrmqJ06xovW9ZYzOaSz+JogpFO7M8WwsRj9+dbWRLoA7BgrhbQ69DPV1BtaRw5VyuUIaL/58qBrDiJ8pnzTD2JQJtx/6M="; npx:hasSignatureTarget this: . this: dct:created "2021-04-04T22:23:57.294+02:00"^^xsd:dateTime; dct:creator orcid:0000-0003-4665-7473; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }